Estimation of the size and shape of GH secretory bursts in healthy women using a physiological estradiol clamp and variable-waveform deconvolution model

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 293, Issue 3, 2007, Pages

  Veldhuis, Johannes D ^a   Keenan, Daniel M ^b   Bowers, Cyril Y ^c  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Estrogen; Female; Ghrelin; Growth hormone releasing hormone; Human; Secretagogues; Somatostatin; Somatotropin

Indexed keywords

ARGININE; ESTROGEN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; PRALMORELIN;

ARTICLE; CLAMP; CONTROLLED STUDY; FEMALE; GROWTH HORMONE RELEASE; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; WAVEFORM; WOMEN'S HEALTH;

AGED; ALGORITHMS; ARGININE; DOUBLE-BLIND METHOD; ESTRADIOL; FEMALE; GROWTH HORMONE-RELEASING HORMONE; HORMONES; HUMAN GROWTH HORMONE; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; MODELS, STATISTICAL; OLIGOPEPTIDES; PROSPECTIVE STUDIES;

EID: 34548447981     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00159.2007     Document Type: Article

References (43)

1. Alba-Roth J, Muller OA, Schopohl J, Von Werder K. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. J Clin Endocrinol Metab 67: 1186-1189, 1988.
2. Arvat E, Ceda GP, Di Vito L, Ramunni J, Gianotti L, Broglio F, Deghenghi R, Ghigo E. Age-related variations in the neuroendocrine control, more than impaired receptor sensitivity, cause the reduction in the GH-releasing activity of GHRPs in human aging. Pituitary 1: 51-58, 1998.
3. Bowers CY. Synergistic release of growth hormone by GHRP and GHRH: scope and implication. In: Growth Hormone Secretagogues in Clinical Practice, edited by Bercu BB and Walker RF. New York: Marcel Dekker, 1998, p. 1-25.
4. Carlsson L, Eriksson E, Seeman H, Jansson JO. Oestradiol increases baseline growth hormone levels in the male rat: possible direct action on the pituitary. Acta Physiol Scand 129: 393-399, 1987.
5. Childs GV, Iruthayanathan M, Akhter N, Unabia G, Whitehead-Johnson B. Bipotential effects of estrogen on growth hormone synthesis and storage in vitro. Endocrinology 146: 1780-1788, 2005.
6. Cho SJ, Jeftinija K, Glavaski A, Jeftinija S, Jena BP, Anderson LL. Structure and dynamics of the fusion pores in live GH-secreting cells revealed using atomic force microscopy. Endocrinology 143: 1144-1148, 2002.
7. Clodfelter KH, Holloway MG, Hodor P, Park SH, Ray WJ, Waxman DJ. Sex-dependent liver gene expression is extensive and largely dependent on signal transducer and activator of transcription 5b (STAT5b): STAT5b-dependent activation of male genes and repression of female genes revealed by microarray analysis. Mol Endocrinol 20: 1333-1351, 2006.
8. De Gennaro Colonna V, Fidone F, Cocchi D, Muller EE. Feedback effects of growth hormone on growth hormone-releasing hormone and somatostatin are not evident in aged rats. Neurobiol Aging 14: 503-507, 1993.
9. De Gennaro Colonna V, Zoli M, Cocchi D, Maggi A, Marrama P, Agnati LF, Mueller EE. Reduced growth hormone releasing factor (GHRF)-like immunoreactivity and GHRF gene expression in the hypothalamus of aged rats. Peptides 10: 705-708, 1989.
10. Farhy LS, Bowers CY, Veldhuis JD. Model-projected mechanistic bases for sex differences in growth-hormone (GH) regulation in humans. Am J Physiol Regul Integr Comp Physiol 292: R1577-R1593, 2007.
11. Faria ACS, Veldhuis JD, Thorner MO, Vance ML. Half-time of endogenous growth hormone (GH) disappearance in normal man after stimulation of GH secretion by GH-releasing hormone and suppression with somatostatin. J Clin Endocrinol Metab 68: 535-541, 1989.
12. Ghigo E, Arvat E, Valente F. Arginine reinstates the somatotrope responsiveness to intermittent growth hormone-releasing hormone administration in normal adults. Neuroendocrinology 54: 291-294, 1991.
13. Goodyer CG, De Stephano L, Guyda HJ, Posner BI. Effects of insulin-like growth factors on adult male rat pituitary function in tissue culture. Endocrinology 115: 1568-1576, 1984.
14. Hataya Y, Akamizu T, Takaya K, Kanamoto N, Ariyasu H, Saijo M, Moriyama K, Shimatsu A, Kojima M, Kangawa K, Nakao K. A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans. J Clin Endocrinol Metab 86: 4552, 2001.
15. Heinzen EL, Pollack GM. Pharmacokinetics and pharmacodynamics of L-arginine in rats: a model of stimulated neuronal nitric oxide synthesis. Brain Res 989: 67-75, 2003.
16. Keenan DM, Chattopadhyay S, Veldhuis JD. Composite model of time-varying appearance and disappearance of neurohormone pulse signals in blood. J Theor Biol 236: 242-255, 2005.
17. Keenan DM, Roelfsema F, Biermasz N, Veldhuis JD. Physiological control of pituitary hormone secretory-burst mass, frequency and waveform: a statistical formulation and analysis. Am J Physiol Regul Integr Comp Physiol 285: R664-R673, 2003.
18. Keenan DM, Veldhuis JD. Disruption of the hypothalamic luteinizing-hormone pulsing mechanism in aging men. Am J Physiol Regul Integr Comp Physiol 281: R1917-R1924, 2001.
19. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402: 656-660, 1999.
20. Kreienkamp HJ, Akgun E, Baumeister H, Meyerhof W, Richter D. Somatostatin receptor subtype 1 modulates basal inhibition of growth hormone release in somatotrophs. FEBS Lett 462: 464-466, 1999.
21. Kuwahara S, Kesuma SD, Tsukamoto Y, Tanaka S, Sasaki F. Age-related changes in growth hormone (GH)-releasing hormone and somatostatin neurons in the hypothalamus and in GH cells in the anterior pituitary of female mice. Brain Res 1025: 113-122, 2004.
22. Low MJ, Otero-Corchon V, Parlow AF, Ramirez JL, Kumar U, Patel YC, Rubinstein M. Somatostatin is required for masculinization of growth hormone-regulated hepatic gene expression but not of somatic growth. J Clin Invest 107: 1571-1580, 2001.
23. Magnan E, Cataldi M, Guillaume V, Conte-Devolx B, Graziani N, Figaroli JC, Thomas F, Chihara K, Oliver C. Acute changes in growth hormone-releasing hormone secretion after injection of BIM 23014, a long acting somatostatin analog, in rams. Life Sci 51: 831-838, 1992.
24. Martinoli MG, Ouellet J, Rheaume E, Pelletier G. Growth hormone and somatostatin gene expression in adult and aging rats as measured by quantitative in situ hybridization. Neuroendocrinology 54: 607-615, 1991.
25. Muccioli G, Ghe C, Ghigo MC, Papotti M, Arvat E, Boghen MF, Nilsson MHL, Deghenghi R, Ong H, Ghigo E. Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland. J Endocrinol 157: 99-106, 1998.
26. Muller EE, Locatelli V, Cocchi D. Neuroendocrine control of growth hormone secretion. Physiol Rev 79: 511-607, 1999.
27. Nakamura S, Mizuno M, Katakami H, Gore AC, Terasawa E. Aging-related changes in in vivo release of growth hormone-releasing hormone and somatostatin from the stalk-median eminence in female rhesus monkeys (Macaca mulatta). J Clin Endocrinol Metab 88: 827-833, 2003.
28. Pantel J, Legendre M, Cabrol S, Hilal L, Hajaji Y, Morisset S, Nivot S, Vie-Luton MP, Grouselle D, de Kerdanet M, Kadiri A, Epelbaum J, Le Bouc Y, Amselem S. Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. J Clin Invest 116: 760-768, 2006.
29. Rudling M, Norstedt G, Olivecrona H, Reihner E, Gustafsson JA, Angelin B. Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. Proc Natl Acad Sci USA 89: 6983-6987, 1992.
30. Russell-Aulet M, Jaffe CA, DeMott-Friberg R, Barkan AL. In vivo semiquantification of hypothalamic growth hormone-releasing hormone (GHRH) output in humans: evidence for relative GHRH deficiency in aging. J Clin Endocrinol Metab 84: 3490-3497, 1999.
31. Shibasaki T, Yamauchi N, Hotta M, Masuda A, Imaki T, Demura H, Ling N, Shizume K. In vivo release of growth hormone-releasing factor from rat hypothalamus: effect of insulin-like growth factor-I. Regul Pept 15: 47-53, 1986.
32. Shimon I, Taylor JE, Dong JZ, Bitonte RA, Kim S, Morgan B, Coy DH, Culler MD, Melmed S. Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation. J Clin Invest 99: 789-798, 1997.
33. Shuto Y, Shibasaki T, Otagiri A, Kuriyama H, Ohata H, Tamura H, Kamegai J, Sugihara H, Oikawa S, Wakabayashi I. Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity. J Clin Invest 109: 1429-1436, 2002.
34. Simard J, Hubert JF, Hosseinzadeh T, Labrie F. Stimulation of growth hormone release and synthesis by estrogens in rat anterior pituitary cells in culture. Endocrinology 119: 2004-2011, 1986.
35. Stachura ME, Tyler JM, Farmer PK. Combined effects of human growth hormone (GH)-releasing factor-44 (GRF) and somatostatin (SRIF) on post-SRIF rebound release of GH and prolactin: a model for GRF-SRIF modulation of secretion. Endocrinology 123: 1476-1482, 1988.
36. Sugihara H, Minami S, Wakabayashi I. Post-somatostatin rebound secretion of growth hormone is dependent on growth hormone-releasing factor in unrestrained female rats. J Endocrinol 122: 583-591, 1989.
37. Valverde I, Penalva A, Ghigo E, Casanueva FF, Dieguez C. Involvement of nitric oxide in the regulation of growth hormone secretion in dogs. Neuroendocrinology 74: 213-219, 2001.
38. Veldhuis JD, Erickson D, Iranmanesh A, Miles JM, Bowers CY. Sex-steroid control of the aging somatotropic axis. Endocrinol Metab Clin North Am 34: 877-893, 2005.
39. Veldhuis JD, Evans WS, Johnson ML. Complicating effects of highly correlated model variables on nonlinear least-squares estimates of unique parameter values and their statistical confidence intervals: estimating basal secretion and neurohormone half-life by deconvolution analysis. Methods Neurosci 28: 130-138, 1995.
40. Veldhuis JD, Roemmich JN, Richmond EJ, Bowers CY. Somatotropic and gonadotropic axes linkages in infancy, childhood, and the puberty-adult transition. Endocr Rev 27: 101-140, 2006.
41. Wren AM, Small CJ, Fribbens CV, Neary NM, Ward HL, Seal LJ, Ghatei MA, Bloom SR. The hypothalamic mechanisms of the hypophysiotropic action of ghrelin. Neuroendocrinology 76: 316-324, 2002.
42. Yan M, Jones ME, Hernandez M, Liu D, Simpson ER, Chen CH. Functional modification of pituitary somatotropes in the aromatase knockout mouse and the effect of estrogen replacement. Endocrinology 145: 604-612, 2004.
43. Zizzari P, Halem H, Taylor J, Dong JZ, Datta R, Culler MD, Epelbaum J, Bluet-Pajot MT. Endogenous ghrelin regulates episodic growth hormone (GH) secretion by amplifying GH pulse amplitude: evidence from antagonism of the GH secretagogue-R1a receptor. Endocrinology 146: 3836-3842, 2005.